BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lee YI, Hong YB, Kim Y, Rho HM, Jung G. RNase H activity of human hepatitis B virus polymerase expressed in Escherichia coli. Biochem Biophys Res Commun. 1997;233:401-407. [PMID: 9144547 DOI: 10.1006/bbrc.1997.6467] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Kim Y, Jung G. Active human hepatitis B viral polymerase expressed in rabbit reticulocyte lysate system. Virus Genes. 1999;19:123-130. [PMID: 10541016 DOI: 10.1023/a:1008175107309] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.0] [Reference Citation Analysis]
2 Chook JB, Ngeow YF, Khang TF, Ng KP, Tiang YP, Mohamed R. Comparative analysis of viral genomes from acute and chronic hepatitis B reveals novel variants associated with a lower rate of chronicity. J Med Virol 2013;85:419-24. [PMID: 23297244 DOI: 10.1002/jmv.23500] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
3 Colacino JM, Staschke KA. The identification and development of antiviral agents for the treatment of chronic hepatitis B virus infection. Prog Drug Res 1998;50:259-322. [PMID: 9670781 DOI: 10.1007/978-3-0348-8833-2_6] [Cited by in Crossref: 38] [Cited by in F6Publishing: 36] [Article Influence: 1.7] [Reference Citation Analysis]
4 Cheng H, Zhang HZ, Shen WA, Liu YF, Ma FC. Expression of RNase H of human hepatitis B virus polymerase in Escherichia coli. World J Gastroenterol 2003;9:513-5. [PMID: 12632508 DOI: 10.3748/wjg.v9.i3.513] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
5 Villa JA, Pike DP, Patel KB, Lomonosova E, Lu G, Abdulqader R, Tavis JE. Purification and enzymatic characterization of the hepatitis B virus ribonuclease H, a new target for antiviral inhibitors. Antiviral Res 2016;132:186-95. [PMID: 27321664 DOI: 10.1016/j.antiviral.2016.06.005] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
6 Tavis JE, Cheng X, Hu Y, Totten M, Cao F, Michailidis E, Aurora R, Meyers MJ, Jacobsen EJ, Parniak MA, Sarafianos SG. The hepatitis B virus ribonuclease H is sensitive to inhibitors of the human immunodeficiency virus ribonuclease H and integrase enzymes. PLoS Pathog 2013;9:e1003125. [PMID: 23349632 DOI: 10.1371/journal.ppat.1003125] [Cited by in Crossref: 79] [Cited by in F6Publishing: 74] [Article Influence: 9.9] [Reference Citation Analysis]
7 Staschke KA, Colacino JM. Drug discovery and development of antiviral agents for the treatment of chronic hepatitis B virus infection. Prog Drug Res. 2001;Spec No:111-183. [PMID: 11548207 DOI: 10.1007/978-3-0348-7784-8_4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
8 De Vivo M, Dal Peraro M, Klein ML. Phosphodiester cleavage in ribonuclease H occurs via an associative two-metal-aided catalytic mechanism. J Am Chem Soc 2008;130:10955-62. [PMID: 18662000 DOI: 10.1021/ja8005786] [Cited by in Crossref: 112] [Cited by in F6Publishing: 89] [Article Influence: 8.6] [Reference Citation Analysis]
9 Frazier AD, Champney WS. The vanadyl ribonucleoside complex inhibits ribosomal subunit formation in Staphylococcus aureus. J Antimicrob Chemother 2012;67:2152-7. [PMID: 22643191 DOI: 10.1093/jac/dks182] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
10 Gong Y, Yao E, Tavis JE. Evidence that the RNAseH activity of the duck hepatitis B virus is unable to act on exogenous substrates. BMC Microbiol 2001;1:12. [PMID: 11504562 DOI: 10.1186/1471-2180-1-12] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
11 Sípová H, Vaisocherová H, Stěpánek J, Homola J. A dual surface plasmon resonance assay for the determination of ribonuclease H activity. Biosens Bioelectron 2010;26:1605-11. [PMID: 20829018 DOI: 10.1016/j.bios.2010.08.011] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
12 Tavis JE, Lomonosova E. The hepatitis B virus ribonuclease H as a drug target. Antiviral Res. 2015;118:132-138. [PMID: 25862291 DOI: 10.1016/j.antiviral.2015.04.002] [Cited by in Crossref: 48] [Cited by in F6Publishing: 37] [Article Influence: 8.0] [Reference Citation Analysis]
13 Potenza N, Salvatore V, Raimondo D, Falanga D, Nobile V, Peterson DL, Russo A. Optimized expression from a synthetic gene of an untagged RNase H domain of human hepatitis B virus polymerase which is enzymatically active. Protein Expr Purif 2007;55:93-9. [PMID: 17507239 DOI: 10.1016/j.pep.2007.04.005] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.0] [Reference Citation Analysis]